Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 8(11): e81309, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24312288

RESUMO

Cell permeable peptides (CPP) aid cellular uptake of targeted cargo across the hydrophobic plasma membrane. CPP-mediated cargo delivery of receptor signaling motifs provides an opportunity to regulate specific receptor initiated signaling cascades. Both endothelin-1 receptors, ETA and ETB, have been targets of antagonist therapies for individuals with pulmonary arterial hypertension (PAH). These therapies have had success but have been accompanied by adverse reactions. Also, unlike the CPP which target specific signaling cascades, the antagonists target the entire function of the receptor. Using the CPP strategy of biased antagonism of the ETB receptor's intracellular loop 2 (ICB2), we demonstrate blunting of hypoxic pulmonary hypertension (HPH) in the rat, including indices of pulmonary arterial pressure, right ventricular hypertrophy and pulmonary vascular remodeling. Further, ex vivo analysis of the pulmonary artery treated with the IC2B peptide upon injection manifests marked reductions in Akt and ERK activation. Both kinases have been intimately related to cell proliferation and vascular contraction, the hallmarks of PAH. These observations in sum illustrate an involvement of the ETB receptor in HPH and furthermore provide a basis for a novel, CPP-based, strategy in the treatment of PAH, ultimately able to target not only ET-1, but also other factors involved in the development of PAH.


Assuntos
Peptídeos Penetradores de Células/farmacologia , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/tratamento farmacológico , Hipóxia/complicações , Espaço Intracelular/metabolismo , Terapia de Alvo Molecular , Receptor de Endotelina B/metabolismo , Animais , Peptídeos Penetradores de Células/metabolismo , Peptídeos Penetradores de Células/uso terapêutico , Endotelina-1/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Hipertensão Pulmonar/patologia , Hipertensão Pulmonar/fisiopatologia , Espaço Intracelular/efeitos dos fármacos , Masculino , Proteínas Proto-Oncogênicas c-akt/metabolismo , Artéria Pulmonar/efeitos dos fármacos , Artéria Pulmonar/fisiopatologia , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos
2.
Mol Biosyst ; 6(8): 1381-8, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20464001

RESUMO

Intramolecular hydrogen bonding is an important determinant of enzyme structure, catalysis, and inhibitor action. Monoacylglycerol lipase (MGL) modulates cannabinergic signaling as the main enzyme responsible for deactivating 2-arachidonoylglycerol (2-AG), a primary endocannabinoid lipid messenger. By enhancing tissue-protective 2-AG tone, targeted MGL inhibitors hold therapeutic promise for managing pain and treating inflammatory and neurodegenerative diseases. We report study of purified, solubilized human MGL (hMGL) to explore the details of hMGL catalysis by using two known covalent hMGL inhibitors, the carbamoyl tetrazole AM6701 and N-arachidonoylmaleimide (NAM), that act through distinct mechanisms. Using proton nuclear magnetic resonance spectroscopy (NMR) with purified wild-type and mutant hMGLs, we have directly observed a strong hydrogen-bond network involving Asp239 and His269 of the catalytic triad and neighboring Leu241 and Cys242 residues. hMGL inhibition by AM6701 alters this hydrogen-bonding pattern through subtle active-site structural rearrangements without influencing hydrogen-bond occupancies. Rapid carbamoylation of hMGL Ser122 by AM6701 and elimination of the leaving group is followed by a slow hydrolysis of the carbamate group, ultimately regenerating catalytically competent hMGL. In contrast, hMGL titration with NAM, which leads to cysteine alkylation, stoichiometrically decreases the population of the active-site hydrogen bonds. NAM prevents reformation of this network, and in this manner inhibits hMGL irreversibly. These data provide detailed molecular insight into the distinctive mechanisms of two covalent hMGL inhibitors and implicate a hydrogen-bond network as a structural feature of hMGL catalytic function.


Assuntos
Inibidores Enzimáticos/farmacocinética , Espectroscopia de Ressonância Magnética/métodos , Monoacilglicerol Lipases/antagonistas & inibidores , Monoacilglicerol Lipases/química , Monoacilglicerol Lipases/metabolismo , Substituição de Aminoácidos/genética , Catálise/efeitos dos fármacos , Domínio Catalítico/efeitos dos fármacos , Domínio Catalítico/genética , Domínio Catalítico/fisiologia , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/metabolismo , Humanos , Ligação de Hidrogênio/efeitos dos fármacos , Técnicas In Vitro , Cinética , Monoacilglicerol Lipases/genética , Mutagênese Sítio-Dirigida , Tetrazóis/metabolismo , Tetrazóis/farmacocinética
3.
Chem Biol Drug Des ; 76(1): 70-6, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20492449

RESUMO

A cell-penetrating peptide consisting of the second intracellular loop (IC2) of the angiotensin II (AngII) type-I receptor (AT1) linked to the HIV-transactivating regulatory protein (TAT) domain was used to identify the role of this motif In intracellular signal transduction. HEK-293 cells stably transfected with AT1R cDNA and primary cultures of human pulmonary artery smooth muscle cells expressing endogenous AT1 receptor were exposed to the cell-penetrating peptide construct, and the effect on angiotensin II signaling was determined. The AT1 IC2 peptide effectively inhibited AngII-stimulated phosphatidylinositol turnover and calcium influx. It also limited the activation of Akt/PKB as determined by an inhibition of phosphorylation of Akt at Ser473, and completely abolished the AngII-dependent activation of the transcriptional factor NFkappaB. In contrast, the AT1 IC2 peptide had no effect on AngII/AT1 receptor activation of ERK. These results illustrate the potential of using cell-penetrating peptides to both delineate receptor-mediated signal transduction and to selectively regulate G protein-coupled receptor signaling.


Assuntos
Angiotensina II/metabolismo , Peptídeos/química , Peptídeos/farmacologia , Receptor Tipo 1 de Angiotensina/química , Transdução de Sinais/efeitos dos fármacos , Produtos do Gene tat do Vírus da Imunodeficiência Humana/química , Linhagem Celular , Células Cultivadas , Humanos , Miócitos de Músculo Liso/efeitos dos fármacos , Miócitos de Músculo Liso/metabolismo , Estrutura Terciária de Proteína , Artéria Pulmonar/citologia , Receptor Tipo 1 de Angiotensina/genética , Transfecção
4.
Biochemistry ; 44(17): 6392-403, 2005 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-15850373

RESUMO

The invariance of NMR residual dipolar couplings (RDCs) in denatured forms of staphylococcal nuclease to changes in denaturant concentration or amino acid sequence has previously been attributed to the robustness of long-range structure in the denatured state. Here we compare RDCs of the wild-type nuclease with those of a fragment that retains a folded OB-fold subdomain structure despite missing the last 47 of 149 residues. The RDCs of the intact protein and of the truncation fragment are substantially different under conditions that favor folded structure. By contrast, there is a strong correlation between the RDCs of the full-length protein and the fragment under denaturing conditions (6 M urea). The RDCs of the folded and unfolded forms of the proteins are uncorrelated. Our results suggest that RDCs are more sensitive to structural changes in folded than unfolded proteins. We propose that the greater susceptibility of RDCs in folded states is a consequence of the close packing of the polypeptide chain under native conditions. By contrast, the invariance of RDCs in denatured states is more consistent with a disruption of cooperative structure than with the retention of a unique long-range folding topology.


Assuntos
Nuclease do Micrococo/química , Modelos Químicos , Modelos Moleculares , Ressonância Magnética Nuclear Biomolecular/métodos , Dobramento de Proteína , Termodinâmica , Anisotropia , Bacteriófago Pf1/química , Simulação por Computador , Cristalografia por Raios X , Estabilidade Enzimática/genética , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Genes Supressores , Modelos Lineares , Nuclease do Micrococo/genética , Nuclease do Micrococo/metabolismo , Mutação , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/metabolismo , Desnaturação Proteica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA